FNDC5 and ischemic stroke: Moreover, it has been demonstrated that during ischemic stroke, irisin exerts its beneficial role by inhibiting ROS-NLRP3 signaling in vivo [56] and through suppression of TLR4/MYD88 signaling pathways in vitro [57].